Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

Pigio™ ICU: Gaze-to-Speech app analytics for January 11

Pigio™ ICU: Gaze-to-Speech

Pigio™ ICU: Gaze-to-Speech

  • 10032506 Canada Inc
  • Apple App Store
  • Free
  • Medical
Pigio™ allows you to control its mobile interface using your eyes. The Pigio™ ICU app will turn your iPad into an intuitive communication tool. Through the combination of Apple’s text to speech and our innovative eye movement tracking technology, Pigio™ ICU enables users to gaze at icons triggering a Gaze-to-Speech™ engine. No hand movements are required. Contrary to infrared eye-tracking solutions, Pigio™ ICU works even if the user is wearing glasses or in a sunny environment. If you are a healthcare professional or caregiver and want to improve communication for people without a voice, you can consider Pigio™ the new standard of digital accessibility. Multilingual (English, French, Spanish). End user licence agreement: https://innodemneurosciences.com/eula Privacy Policy: https://innodemneurosciences.com/privacy-policy

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

Pigio™ ICU: Gaze-to-Speech Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Pigio™ ICU: Gaze-to-Speech

Rank

No Data Available

Pigio™ ICU: Gaze-to-Speech Ranking by Country

Counties in which Pigio™ ICU: Gaze-to-Speech has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

EyeCanDo

EyeCanDo

Rui Liu

Communicare ICU

Communicare ICU

Communicare OU

Eye Tracking Speech- GazeyTalk

Eye Tracking Speech- GazeyTalk

Intiser Ahmed Ahmed

Eye Gaze Communication Board

Eye Gaze Communication Board

Jeffrey Ebin

Pigio™ ICU: Gaze-to-Speech VS.

January 11, 2026